Eto Masaaki 衛藤雅昭

… Alternative Names

Researcher Number	90133818
Affiliation (Current)	2022: 奥羽大学, 薬学部, 教授
Affiliation (based on the past Project Information) *help	2007 – 2008: Ohu University, 薬学部, 教授 2000 – 2003: 川崎医科大学, 医学部, 助教授 1998: 川崎医科大学, 助教授 1996 – 1997: 旭川医科大学, 医学部, 助教授 1993 – 1994: 旭川医科大学, 医学部, 助教授
Review Section/Research Field	Principal Investigator Metabolomics / Medical pharmacy / 内科学一般 Except Principal Investigator Pathological medical chemistry
Keywords	Principal Investigator 糖尿病性腎症 / レムナントリポ蛋白 / TGF-β / トリグリセライド / atherogenicity / アポE2 / アポE遺伝型 / メサンギウム細胞 / PKC活性 / diabetic nephropathy … More Except Principal Investigator 脂肪負荷試験 / 食後高脂血症 / 負荷脂肪 / トリグリセライド / レムナント様リポ蛋白 / 最大無作用量 / 潜在的危険因子 / 負荷脂肪の安全性 / 脂肪負荷後採血時間 / 脂肪負荷後測定項目 / 高トリグリセライド血症 / レムナント様粒子 / カイロミクロン / レチノールパルミテート / 凝固線溶系因子 / 動脈硬化 Less

Risk factors for diabetic nephropathy (apolipoprotein E2 allele and remnant lipoproteins) and drug interventionPrincipal Investigator
- Principal Investigator
  
  ETO Masaaki
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Ohu University
Study on the mechanism by which apolipoprotein(apo) E2 promotes diabetic nephropathyPrincipal Investigator
- Principal Investigator
  
  ETO Masaaki
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Metabolomics
- Research Institution
  Kawasaki Medical School
Diabetic nephropathy and apolipoprotein E2 allelePrincipal Investigator
- Principal Investigator
  
  ETO Masaaki
- Project Period (FY)
  2000 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Metabolomics
- Research Institution
  KAWASAKI MEDICAL SCHOOL
動脈硬化の潜在的促進因子早期発見のための脂肪負荷試験の開発と実用化に関する研究
- Principal Investigator
  
  秦葭哉
- Project Period (FY)
  1996 – 1998
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  Kyorin University
Study on the significance of apo E in aherosclerosisPrincipal Investigator
- Principal Investigator
  
  ETO Masaaki
- Project Period (FY)
  1993 – 1994
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  内科学一般
- Research Institution
  Asahikawa Medical College

All 2009 2008 2007

All Journal Article Presentation Book

[Book] 「変わる脳梗塞の再発予防~薬物療法と血圧・脂質・血糖管理」Mebio 26 巻糖尿病治療と脳梗塞の再発予防2009
- Author(s)
  衛藤雅昭、服部由香、斉藤美恵子
- Publisher
  メジカルビュー社
- Data Source
  KAKENHI-PROJECT-19590155
[Book] 「脂質異常症-基本を踏まえた実践」内科103 巻 III型高脂血症2009
- Author(s)
  衛藤雅昭、服部由香、上妻いくえ、斉藤美恵子
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-19590155
[Book] 脂質異常症-III型高脂血症2009
- Author(s)
  衛藤雅昭, 服部由香, 上妻いくえ, 斉藤美恵子
- Total Pages
  5
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-19590155
[Book] 「大規模臨床試験」糖尿病における大規模臨床試験スタチン系薬剤2008
- Author(s)
  衛藤雅昭、服部由香、斉藤美恵子
- Publisher
  日本臨床社
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Bezafibrate suppresses the expression of TGF-β and type IV collagen in human mesangial cells loaded with remnant lipoproteins2009
- Author(s)
  Terasawa R, Hattori Y, Agatsuma I,Saito M, Eto M
- Journal Title
  
  Jpn Pharmacol Ther 36
  
  Pages: 117-122
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Bezafibrate suppresses the expression of TGF-βand type IV collagen in human mesangial cells loaded with remnant lipoproteins2009
- Author(s)
  Terasawa R, Hattori Y, Agatsuma I, Saito M, Eto M
- Journal Title
  
  Jpn Pharmacol Ther 37
  
  Pages: 117-122
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Effectiveness and safety of ezetimibe monotherapy in hyperlipidemic patients-Ezetimibe reduces plasma remnant cholesterol-2009
- Author(s)
  Saito M. Kumanomido A. Takigami S, Hattori Y. Agatsum I, Terasawa R, Eto M
- Journal Title
  
  Jpn Pharmacol Ther 36
  
  Pages: 411-416
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Effectiveness and safety of ezetimibe monotherapy in hyperlipidemic patients. -Ezetimibe reduces plasma remnant cholesterol-2008
- Author(s)
  Saito M, Kumanomido A, Takigami S, Hattori Y, Agatsuma I, Terasawa R, Eto M
- Journal Title
  
  Jpn Pharmacol Ther 36
  
  Pages: 411-416
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Effectiveness and safety of the combination therapy of pitavastatin and bezafibrate in type 2 diabetic patients with type Iib hyperlipidemia2008
- Author(s)
  Saito M, Kumanomido A, Takigami S, Eto M
- Journal Title
  
  Jpn Pharmacol Ther 36
  
  Pages: 317-323
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Lipids behavior and adverse effects for oral antidiabetic agents in patients with type 2 diabetes treated with sulfonylureas alone based on systematic review2007
- Author(s)
  Mukai J, Tada H, Watanabe Y, Miura M, Katsuyama S, Shouji T. Mori K, Eto M, Suzuki T
- Journal Title
  
  YAKAGAKU ZASSHI 127
  
  Pages: 1747-1756
- NAID
  110006402960
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Accelerated nephropathy in type 2 diabetic patients with type III hyperlipoproteinemia,and the detrimental effects of their remnant lipoproteins on human mesangial cells2007
- Author(s)
  Saito M, Eto M
- Journal Title
  
  Diabetologia 50 (Suppl.
  
  Pages: 51-52
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Accelerated nephropathy in type 2 diabetic patients with type III hyperlipoproteinemia (apo E2/2 genotype), and the detrimental effects of their remnant lipoproteins on human mesangial cells2007
- Author(s)
  Saito M, Eto M
- Journal Title
  
  Diabetologia (Suppl.)
  
  Pages: 31-32
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency2007
- Author(s)
  Okubo M, Horinishi A, Saito M, Ebara T, Endo Y, Kaku K, Murase T, Eto M
- Journal Title
  
  Molecular Genetics and Metabolism 92
  
  Pages: 229-233
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] Effectiveness and safety of rosuvastatin administration in type 2 diabetic patients with hypercholesterolemia2007
- Author(s)
  Saito M, Takigami S, Tominaga M, Eto M
- Journal Title
  
  Jpn Pharmacol Ther 35
  
  Pages: 1077-1083
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Journal Article] A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency2007
- Author(s)
  Okubo M, Horinishi A, Saito M, Ebara T, Endo Y, Kaku K, Murase T, Eto M.
- Journal Title
  
  Molecular Genetics and Metabolism 92
  
  Pages: 229-233
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590155
[Presentation] Bezafibrate suppresses the expression of TGF-β and type IV collagen mRNA in human mesangial cells loaded with remnant lipoproteins2009
- Author(s)
  Eto M, Hattori Y, Terasawa R, Saito M
- Organizer
  The 45^<rd> EASD Annual Meeting (欧州糖尿病学会)
- Place of Presentation
  ウィーン
- Data Source
  KAKENHI-PROJECT-19590155
[Presentation] 中性脂肪、なぜ、どうやって、どこまで下げるか-中性脂肪管理の重要性2008
- Author(s)
  衛藤雅昭, 斉藤美恵子
- Organizer
  第51回日本糖尿病学会
- Place of Presentation
  東京
- Year and Date
  2008-05-22
- Data Source
  KAKENHI-PROJECT-19590155
[Presentation] Remnant lipoproteins and small dense LDL in patients with the metabolic syndrome2008
- Author(s)
  Saito M, Eto M
- Organizer
  The 77^<th> EAS congress(欧州動脈硬化学会)
- Place of Presentation
  イスタンブール
- Data Source
  KAKENHI-PROJECT-19590155
[Presentation] Accelerated nephropathy in type 2 diabetic patients with type III hyperlipoproteinemia (apo E2/2 genotype), and the detrimental effects of their remnant lipoproteins on human mesangial cells2007
- Author(s)
  Saito M, Eto M
- Organizer
  The 43^<rd> EASD Annual Meeting (欧州糖尿病学会)
- Place of Presentation
  アムステルダム
- Year and Date
  2007-09-18
- Data Source
  KAKENHI-PROJECT-19590155
[Presentation] Accelerated nephropathy in type 2 diabetic patients with type III hyperlipoproteinemia,and the detrimental effects of their remnant lipoproteins on human mesangial cells2007
- Author(s)
  Saito M, Eto M
- Organizer
  The 43rd EASD Annual Meeting(欧州糖尿病学会)
- Place of Presentation
  Amsterdam
- Year and Date
  2007-09-18
- Data Source
  KAKENHI-PROJECT-19590155

1. SAITO Mieko (60319952)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 秦葭哉 (70051258)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 及川眞一 (30142946)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 多田紀夫 (60138774)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 田中明 (70171733)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 板倉弘重

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Eto Masaaki 衛藤 雅昭

ETO Masaaki 衛藤 雅昭

衛藤 雅昭 エトウ マサアキ

Research Projects

Research Products

Co-Researchers

Risk factors for diabetic nephropathy (apolipoprotein E2 allele and remnant lipoproteins) and drug interventionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study on the mechanism by which apolipoprotein(apo) E2 promotes diabetic nephropathyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Diabetic nephropathy and apolipoprotein E2 allelePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

動脈硬化の潜在的促進因子早期発見のための脂肪負荷試験の開発と実用化に関する研究

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study on the significance of apo E in aherosclerosisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 「変わる脳梗塞の再発予防~薬物療法と血圧・脂質・血糖管理」Mebio 26 巻 糖尿病治療と脳梗塞の再発予防2009

Author(s)

Publisher

Data Source

[Book] 「脂質異常症-基本を踏まえた実践」内科103 巻 III型高脂血症2009

Author(s)

Publisher

Data Source

[Book] 脂質異常症-III型高脂血症2009

Author(s)

Total Pages

Publisher

Data Source

[Book] 「大規模臨床試験」糖尿病における大規模臨床試験 スタチン系薬剤2008

Author(s)

Publisher

Data Source

[Journal Article] Bezafibrate suppresses the expression of TGF-β and type IV collagen in human mesangial cells loaded with remnant lipoproteins2009

Author(s)

Journal Title

Data Source

[Journal Article] Bezafibrate suppresses the expression of TGF-βand type IV collagen in human mesangial cells loaded with remnant lipoproteins2009

Author(s)

Journal Title

Data Source

[Journal Article] Effectiveness and safety of ezetimibe monotherapy in hyperlipidemic patients-Ezetimibe reduces plasma remnant cholesterol-2009

Author(s)

Journal Title

Data Source

[Journal Article] Effectiveness and safety of ezetimibe monotherapy in hyperlipidemic patients. -Ezetimibe reduces plasma remnant cholesterol-2008

Author(s)

Journal Title

Data Source

[Journal Article] Effectiveness and safety of the combination therapy of pitavastatin and bezafibrate in type 2 diabetic patients with type Iib hyperlipidemia2008

Author(s)

Journal Title

Data Source

[Journal Article] Lipids behavior and adverse effects for oral antidiabetic agents in patients with type 2 diabetes treated with sulfonylureas alone based on systematic review2007

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Accelerated nephropathy in type 2 diabetic patients with type III hyperlipoproteinemia,and the detrimental effects of their remnant lipoproteins on human mesangial cells2007

Author(s)

Eto Masaaki 衛藤雅昭

ETO Masaaki 衛藤雅昭

衛藤雅昭エトウマサアキ

[Book] 「変わる脳梗塞の再発予防~薬物療法と血圧・脂質・血糖管理」Mebio 26 巻糖尿病治療と脳梗塞の再発予防2009

[Book] 「大規模臨床試験」糖尿病における大規模臨床試験スタチン系薬剤2008